A global survey of potential acceptance of a COVID-19 vaccine

Several coronavirus disease 2019 (COVID-19) vaccines are currently in human trials. In June 2020, we surveyed 13,426 people in 19 countries to determine potential acceptance rates and factors influencing acceptance of a COVID-19 vaccine. Of these, 71.5% of participants reported that they would be ve...

Full description

Saved in:
Bibliographic Details
Published inNature medicine Vol. 27; no. 2; pp. 225 - 228
Main Authors Lazarus, Jeffrey V., Ratzan, Scott C., Palayew, Adam, Gostin, Lawrence O., Larson, Heidi J., Rabin, Kenneth, Kimball, Spencer, El-Mohandes, Ayman
Format Journal Article
LanguageEnglish
Published New York Nature Publishing Group US 01.02.2021
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Several coronavirus disease 2019 (COVID-19) vaccines are currently in human trials. In June 2020, we surveyed 13,426 people in 19 countries to determine potential acceptance rates and factors influencing acceptance of a COVID-19 vaccine. Of these, 71.5% of participants reported that they would be very or somewhat likely to take a COVID-19 vaccine, and 48.1% reported that they would accept their employer’s recommendation to do so. Differences in acceptance rates ranged from almost 90% (in China) to less than 55% (in Russia). Respondents reporting higher levels of trust in information from government sources were more likely to accept a vaccine and take their employer’s advice to do so. Survey data from across 19 countries reveal heterogeneity in attitudes toward acceptance of a COVID-19 vaccine and suggest that trust in government is associated with vaccine confidence.
ISSN:1078-8956
1546-170X
DOI:10.1038/s41591-020-1124-9